WATSON 3209 Pill - yellow capsule/oblong, 18mm
Pill with imprint WATSON 3209 is Yellow, Capsule/Oblong and has been identified as Rivastigmine Tartrate 3 mg. It is supplied by Watson Pharmaceuticals.
Rivastigmine is used in the treatment of Parkinson's Disease; Alzheimer's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 3209
Rivastigmine Tartrate
- Imprint
- WATSON 3209
- Strength
- 3 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
gelatin,
titanium dioxide,
ferric oxide yellow,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
shellac,
propylene glycol
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3209 (Discontinued) | Watson Pharmaceuticals, Inc. |
| 63739-0577 (Discontinued) | McKesson Packaging Services |
More about rivastigmine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (39)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: cholinesterase inhibitors
Patient resources
- Rivastigmine drug information
- Rivastigmine transdermal
- Rivastigmine (Oral) (Advanced Reading)
- Rivastigmine (Transdermal) (Advanced Reading)
- Rivastigmine Capsules
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.